BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cevaal PM, Ali A, Czuba-Wojnilowicz E, Symons J, Lewin SR, Cortez-Jugo C, Caruso F. In Vivo T Cell-Targeting Nanoparticle Drug Delivery Systems: Considerations for Rational Design. ACS Nano 2021;15:3736-53. [PMID: 33600163 DOI: 10.1021/acsnano.0c09514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Est-witte SE, Livingston NK, Omotoso MO, Green JJ, Schneck JP. Nanoparticles for generating antigen-specific T cells for immunotherapy. Seminars in Immunology 2021. [DOI: 10.1016/j.smim.2021.101541] [Reference Citation Analysis]
2 Chen Y, Sun W, Tang H, Li Y, Li C, Wang L, Chen J, Lin W, Li S, Fan Z, Cheng Y, Chen C. Interactions Between Immunomodulatory Biomaterials and Immune Microenvironment: Cues for Immunomodulation Strategies in Tissue Repair. Front Bioeng Biotechnol 2022;10:820940. [DOI: 10.3389/fbioe.2022.820940] [Reference Citation Analysis]
3 Sharma N, Bietar K, Stochaj U. Targeting nanoparticles to malignant tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2022. [DOI: 10.1016/j.bbcan.2022.188703] [Reference Citation Analysis]
4 Lou J, Heater A, Zheng G. Improving the Delivery of Drugs and Nucleic Acids to T Cells Using Nanotechnology. Small Structures 2021;2:2100026. [DOI: 10.1002/sstr.202100026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Tanaka H, Miyama R, Sakurai Y, Tamagawa S, Nakai Y, Tange K, Yoshioka H, Akita H. Improvement of mRNA Delivery Efficiency to a T Cell Line by Modulating PEG-Lipid Content and Phospholipid Components of Lipid Nanoparticles. Pharmaceutics 2021;13:2097. [PMID: 34959378 DOI: 10.3390/pharmaceutics13122097] [Reference Citation Analysis]
6 Su FY, Zhao QH, Dahotre SN, Gamboa L, Bawage SS, Silva Trenkle AD, Zamat A, Phuengkham H, Ahmed R, Santangelo PJ, Kwong GA. In vivo mRNA delivery to virus-specific T cells by light-induced ligand exchange of MHC class I antigen-presenting nanoparticles. Sci Adv 2022;8:eabm7950. [PMID: 35196075 DOI: 10.1126/sciadv.abm7950] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yu P, Liu Y, Xie J, Li J. Spatiotemporally controlled calcitonin delivery: Long-term and targeted therapy of skeletal diseases. J Control Release 2021;338:486-504. [PMID: 34481022 DOI: 10.1016/j.jconrel.2021.08.056] [Reference Citation Analysis]
8 Chen H, Shi T, Wang Y, Liu Z, Liu F, Zhang H, Wang X, Miao Z, Liu B, Wan M, Mao C, Wei J. Deep Penetration of Nanolevel Drugs and Micrometer-Level T Cells Promoted by Nanomotors for Cancer Immunochemotherapy. J Am Chem Soc 2021;143:12025-37. [PMID: 34320319 DOI: 10.1021/jacs.1c03071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Hossain MS, Ji J, Lynch CJ, Guzman M, Nangia S, Mozhdehi D. Adaptive Recombinant Nanoworms from Genetically Encodable Star Amphiphiles. Biomacromolecules 2021. [PMID: 34942072 DOI: 10.1021/acs.biomac.1c01314] [Reference Citation Analysis]
10 Cortez-Jugo C, Czuba-Wojnilowicz E, Tan A, Caruso F. A Focus on "Bio" in Bio-Nanoscience: The Impact of Biological Factors on Nanomaterial Interactions. Adv Healthc Mater 2021;10:e2100574. [PMID: 34170631 DOI: 10.1002/adhm.202100574] [Reference Citation Analysis]
11 Ferguson LT, Hood ED, Shuvaeva T, Shuvaev VV, Basil MC, Wang Z, Nong J, Ma X, Wu J, Myerson JW, Marcos-Contreras OA, Katzen J, Carl JM, Morrisey EE, Cantu E, Villa CH, Mitragotri S, Muzykantov VR, Brenner JS. Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers. ACS Nano 2022. [PMID: 35266686 DOI: 10.1021/acsnano.1c11374] [Reference Citation Analysis]
12 Li L, Zhang Q, Chen B, Guo M, Yang Q, Zhang Y, Zhang M. Nano-Bio Interface-Guided Nanoparticle Protein Corona Antigen for Immunoassays and Immunoimaging in a Complex Matrix. ACS Appl Bio Mater 2022. [PMID: 35113530 DOI: 10.1021/acsabm.1c01231] [Reference Citation Analysis]
13 Kim WJ, Kim GR, Cho HJ, Choi JM. The Cysteine-Containing Cell-Penetrating Peptide AP Enables Efficient Macromolecule Delivery to T Cells and Controls Autoimmune Encephalomyelitis. Pharmaceutics 2021;13:1134. [PMID: 34452095 DOI: 10.3390/pharmaceutics13081134] [Reference Citation Analysis]